$40.65
0.040.10%
al cierre: Nov 19, 4:00 PM EST
$40.65
N/A
After hour: 4:00 PM EST
Comments
Loading...
Xenon Pharmaceuticals Actividad de operaciones con información privilegiada
XENENASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Xenon Pharmaceuticals. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Xenon Pharmaceuticals.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Xenon Pharmaceuticals Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Xenon Pharmaceuticals Inc
Acciones en circulación
77.106M
Acciones en manos de personas con información privilegiada
547.990K
Porcentaje de acciones en manos de personas con información privilegiada
0.71%
Acciones en manos de instituciones
46.465M
Porcentaje de acciones en manos de instituciones
60.1%
Oct 01, 2025 | PRESIDENT, CEO & INTERIM CFO | 0.00 | $23.92 | -$811.75K | SELL-OPTIONS | 0.00% | 45.60K | Oct 01 | ||
Jun 06, 2025 | — | -3.00 | $30.48 | -$91.44 | SELL | -0.04% | 7.14K | Jun 05 | ||
Jan 27, 2025 | PRESIDENT & CEO | 0.00 | $29.01 | -$1.24M | SELL-OPTIONS | 0.00% | 45.60K | Jan 23 - Jan 27 | ||
Dec 19, 2024 | CHIEF FINANCIAL OFFICER | 0.00 | $26.01 | -$771.00K | SELL-OPTIONS | 0.00% | 0.00 | Dec 18 | ||
Nov 22, 2024 | — | 0.00 | $25.50 | -$200.98K | SELL-OPTIONS | 0.00% | 28.48K | Nov 22 | ||
Mar 11, 2024 | — | 0.00 | $32.22 | -$95.62K | SELL-OPTIONS | 0.00% | 0.00 | Mar 08 | ||
Mar 08, 2024 | EVP, STRATEGY & INNOVATION | 0.00 | $28.04 | -$314.30K | SELL-OPTIONS | 0.00% | 8.40K | Mar 07 | ||
Mar 08, 2024 | — | -13.00K | $46.28 | -$601.61K | SELL | -86.67% | 2.00K | Mar 07 | ||
Dec 15, 2023 | — | -7.60K | $24.75 | -$741.41K | SELL | -60.78% | 4.90K | Dec 13 | ||
Aug 24, 2023 | — | -25.00K | $38.70 | -$967.50K | SELL | -50.00% | 25.00K | Aug 24 | ||
Jun 01, 2023 | — | -49.01K | $27.03 | -$5.05M | SELL | -89.09% | 6.00K | May 30 - Jun 01 | ||
May 26, 2023 | PRESIDENT & CEO | 25.30K | $25.57 | -$1.16M | SELL-OPTIONS | 124.64% | 45.60K | May 24 | ||
Mar 24, 2023 | CHIEF MEDICAL OFFICER | -700.00 | $35.01 | -$24.51K | SELL | -100.00% | 0.00 | Mar 24 | ||
Mar 09, 2023 | DIRECTOR | 49.01K | $19.82 | -$661.25K | SELL-OPTIONS | 816.77% | 55.01K | Mar 07 | ||
Nov 28, 2022 | DIRECTOR | -2.06K | $18.61 | -$136.61K | SELL | -5.39% | 36.07K | Nov 23 - Nov 25 | ||
Sep 07, 2022 | CHIEF FINANCIAL OFFICER | 0.00 | $23.27 | -$607.71K | SELL-OPTIONS | 0.00% | 0.00 | Sep 02 | ||
Sep 02, 2022 | EVP, STRATEGY & INNOVATION | -436.00 | $21.30 | -$2.49M | SELL | -2.53% | 16.80K | Aug 31 - Sep 01 | ||
Aug 16, 2022 | EVP, DRUG DISCOVERY | 0.00 | $21.26 | -$2.21M | SELL-OPTIONS | 0.00% | 10.00K | Aug 12 | ||
Aug 16, 2022 | DIRECTOR | -177.13K | $38.25 | -$6.78M | SELL | -96.72% | 6.00K | Aug 12 - Aug 16 | ||
Mar 08, 2022 | DIRECTOR | -27.05K | $16.51 | -$1.59M | SELL | -12.87% | 183.13K | Mar 04 - Mar 08 | ||
Mar 08, 2022 | EVP, STRATEGY & INNOVATION | -15.00K | $17.10 | -$656.90K | SELL | -46.54% | 17.23K | Mar 04 | ||
Mar 08, 2022 | EVP, DRUG DISCOVERY | 0.00 | $19.04 | -$1.57M | SELL-OPTIONS | 0.00% | 10.00K | Mar 04 - Mar 07 | ||
Jan 21, 2022 | CHIEF MEDICAL OFFICER | 700.00 | $28.81 | $20.17K | BUY | ∞ | 700.00 | Jan 21 | ||
Dec 07, 2021 | CHIEF COMMERCIAL OFFICER | 4.00K | $24.40 | $97.60K | BUY | ∞ | 4.00K | Dec 06 | ||
Nov 16, 2021 | DIRECTOR | -17.56K | $31.33 | -$550.06K | SELL | -7.71% | 210.19K | Nov 15 | ||
Jun 01, 2021 | EVP, STRATEGY & INNOVATION | 15.44K | $11.33 | -$95.94K | SELL-OPTIONS | 91.90% | 32.23K | May 28 | ||
Jun 01, 2021 | DIRECTOR | 21.61K | $11.26 | -$180.88K | SELL-OPTIONS | 17.54% | 144.84K | May 27 | ||
Jun 02, 2020 | — | -8.00K | $14.15 | -$113.24K | SELL | -2.86% | 271.65K | May 29 - Jun 01 | ||
Sep 24, 2019 | CEO | -10.39K | $9.51 | -$98.86K | SELL | -3.65% | 274.58K | Sep 20 | ||
Sep 20, 2019 | DIRECTOR | -12.81K | $9.32 | -$119.34K | SELL | -9.72% | 118.95K | Sep 19 - Sep 20 | ||
Sep 18, 2019 | DIRECTOR | -9.44K | $9.30 | -$87.78K | SELL | -6.68% | 131.76K | Sep 17 - Sep 18 | ||
Sep 17, 2019 | DIRECTOR | -23.00 | $9.31 | -$214.18 | SELL | -0.04% | 57.56K | Sep 13 | ||
Nov 16, 2017 | DIRECTOR | 15.00K | $2.22 | $33.28K | BUY | 51.35% | 44.21K | Nov 15 | ||
Sep 25, 2017 | DIRECTOR | 10.00K | $2.95 | $29.50K | BUY | 52.06% | 29.21K | Sep 21 - Sep 22 | ||
Aug 21, 2017 | DIRECTOR | 6.33K | $2.90 | $18.36K | BUY | 49.20% | 19.21K | Aug 17 - Aug 18 | ||
Aug 21, 2017 | HEAD, TRANSLATIONAL RESEARCH | 1.00K | $3.00 | $3.00K | BUY | ∞ | 1.00K | Aug 18 | ||
Aug 17, 2017 | SVP, DRUG DISCOVERY | 10.00K | $2.48 | $24.82K | BUY | ∞ | 10.00K | Aug 15 | ||
Aug 16, 2017 | 10% OWNER | 60.20K | $2.61 | $157.27K | BUY | 4.58% | 1.38M | Aug 14 - Aug 15 | ||
Aug 15, 2017 | DIRECTOR | 50.00K | $2.82 | $140.77K | BUY | ∞ | 50.00K | Aug 14 | ||
Aug 14, 2017 | DIRECTOR | 7.50K | $2.78 | $20.84K | BUY | 44.05% | 24.53K | Aug 10 | ||
Aug 14, 2017 | CFO & COO | 15.00K | $2.88 | $43.23K | BUY | ∞ | 14.30K | Aug 10 | ||
Aug 14, 2017 | DIRECTOR | 7.00K | $2.85 | $19.95K | BUY | ∞ | 7.00K | Aug 10 | ||
Aug 14, 2017 | PRESIDENT & CEO | 6.00K | $2.90 | $17.40K | BUY | 2.63% | 234.31K | Aug 10 | ||
Aug 14, 2017 | DIRECTOR | 15.00K | $2.75 | $41.25K | BUY | 8.50% | 191.53K | Aug 14 | ||
Aug 14, 2017 | DIRECTOR | 15.00K | $2.82 | $42.27K | BUY | ∞ | 15.00K | Aug 11 | ||
Aug 10, 2017 | DIRECTOR | 5.00K | $3.00 | $15.00K | BUY | 41.57% | 17.03K | Aug 08 | ||
Jun 29, 2017 | 10% OWNER | 85.46K | $4.00 | $341.84K | BUY | 40.31% | 297.46K | Jun 27 | ||
Jun 23, 2017 | 10% OWNER | 20.41K | $4.00 | $81.64K | BUY | 7.60% | 288.97K | Jun 21 - Jun 22 | ||
Jun 19, 2017 | 10% OWNER | 26.41K | $3.84 | $101.52K | BUY | 10.14% | 286.75K | Jun 15 - Jun 19 | ||
Jun 08, 2017 | 10% OWNER | 358.70K | $3.81 | $1.37M | BUY | ∞ | 284.17K | Jun 06 - Jun 07 | ||
Dec 19, 2016 | DIRECTOR | -30.00K | $7.85 | -$235.50K | SELL | -20.40% | 117.05K | Dec 15 | ||
Aug 23, 2016 | DIRECTOR | -11.94K | $7.65 | -$91.34K | SELL | -7.51% | 147.05K | Aug 19 | ||
Aug 18, 2016 | DIRECTOR | -18.06K | $7.93 | -$143.16K | SELL | -10.20% | 158.99K | Aug 16 - Aug 18 | ||
Jun 28, 2016 | CFO & COO | 5.30K | $6.22 | $32.94K | BUY | ∞ | 4.30K | Jun 24 | ||
Sep 24, 2015 | VP CLINICAL DEVELOPMENT | -103.00 | $6.15 | -$177.65K | SELL | -1.69% | 6.00K | Sep 22 - Sep 24 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.